Legend Biotech gets FDA IND clearance for LB2501
- FDA cleared IND for LB2501 on 2026-10-15
- LB2501 targets CD19/CD20 for B-cell lymphoma
- Form 6-K filed on 2026-10-15
LEGN
Legend Biotech Corp SEC filings
Every EDGAR filing for Legend Biotech Corp (LEGN), newest first, with AI summaries and stories.
- Ticker
- LEGN
- CIK
- 1801198
- Latest filing
- 4d
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($309K), 7 grants or exercises.
Filings
6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE Legend Biotech reports $710M CARVYKTI sales
- CARVYKTI sales: $710 million for Q3 2026
- Sales data from Janssen, not independently verified
- Revenue recognition pending final financial statements
S-8Legend Biotech CorpLEGNLIVE Legend Biotech files S-8 form
- Filed on 2026-10-07
- Registers 19,100,000 ordinary shares
- Amended and Restated 2020 Restricted Shares Plan
4Legend Biotech CorpLEGNLIVE Sanders Corazon (Corsee) D., insider filing for LEGN
Corazon (Corsee) D. Sanders
144Legend Biotech CorpLEGNLIVE Sanders Corazon (Corsee) D., planned sale of LEGN shares
Corazon (Corsee) D. Sanders, reporting
4Legend Biotech CorpLEGNLIVE 6 insider filings
Sanders Corazon (Corsee) D., insider filing for LEGN
Show all 6
- 4Insider filing for LEGN
- 4Insider filing for LEGN
- 4Insider filing for LEGN
- 4Insider filing for LEGN
- 4Insider filing for LEGN
- 4Insider filing for LEGN
Corazon (Corsee) D. Sanders, reporting
6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 4Legend Biotech CorpLEGNLIVE Carlos E Santos, insider filing for LEGN
Carlos E Santos, reporting
144Legend Biotech CorpLEGNLIVE 2 Form 144 notices
Carlos E Santos, planned sale of LEGN shares
Show all 2
- 144Planned insider sale of LEGN shares
- 144Planned insider sale of LEGN shares
Carlos E Santos, reporting
4Legend Biotech CorpLEGNLIVE 2 insider filings
Ingrid Zhang, insider filing for LEGN
Show all 2
- 4Insider filing for LEGN
- 3New insider at LEGN
Ingrid Zhang, reporting
6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 4Legend Biotech CorpLEGNLIVE Alan Bash, insider filing for LEGN
Alan Bash, reporting
6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE SCHEDULE 13G/ALegend Biotech CorpLEGNLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
3Legend Biotech CorpLEGNLIVE Alan Bash, new insider at LEGN
Alan Bash, reporting
6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 4Legend Biotech CorpLEGNLIVE 2 insider filings
Ying Huang, insider filing for LEGN
Show all 2
- 4Insider filing for LEGN
- 4Insider filing for LEGN
Ying Huang, reporting
144Legend Biotech CorpLEGNLIVE Patrick John Casey, planned sale of LEGN shares
Patrick John Casey, reporting
4Legend Biotech CorpLEGNLIVE Ying Huang, insider filing for LEGN
Ying Huang, reporting
144Legend Biotech CorpLEGNLIVE Ying Huang, planned sale of LEGN shares
Ying Huang, reporting
6-KLegend Biotech CorpLEGNLIVE 424B5Legend Biotech CorpLEGNLIVE 424B5Legend Biotech CorpLEGNLIVE F-6EFLegend Biotech CorpLEGNLIVE JPMorgan Chase Bank, N.A. - ADR Depositary, filed by
6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 6-KLegend Biotech CorpLEGNLIVE 4Legend Biotech CorpLEGNLIVE Ying Huang, insider filing for LEGN
Ying Huang, reporting
144Legend Biotech CorpLEGNLIVE 2 Form 144 notices
Ying Huang, planned sale of LEGN shares
Show all 2
- 144Planned insider sale of LEGN shares
- 144Planned insider sale of LEGN shares
Ying Huang, reporting
3Legend Biotech CorpLEGNLIVE 4 insider filings
Tomas J. Heyman, new insider at LEGN
Show all 4
- 3New insider at LEGN
- 3New insider at LEGN
- 3New insider at LEGN
- 3New insider at LEGN
Tomas J. Heyman, reporting